GENE ONLINE|News &
Opinion
Blog

Monkeypox
Ascletis Cleared By FDA To Begin Trial On Monkeypox Antiviral
2022-11-16
Second Monkeypox Death as Antiviral Enters Phase 3 Clinical Trial
2022-09-12
Monkeypox Update: New FDA Testing Guidelines as the US Passes 20,000 Cases
2022-09-08
HHS Strikes Deal With AmerisourceBergen for Expanded Monkeypox Treatment Distribution
2022-09-07
Monkeypox Cases Fall In The UK But A New Strain Of The Disease Emerges
2022-09-02
Just How Deadly is Monkeypox? Reported Death in Texas While Vaccine Production Ramps Up
2022-09-01
Growing Number of Monkeypox Tests Available to Researchers
2022-08-22
EMA Announces Advice on Switch that Could Increase The Monkeypox Vaccine Supply
2022-08-19
In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine
2022-08-11
Gilead Sciences Promises $5 million to Combat Monkeypox Public Health Emergency
2022-08-09
Three Previously Approved Treatments Show Anti-monkeypox Activity
2022-08-08
BD, CerTest Commercialize Research-Use Monkeypox Test Amidst Rising Cases
2022-07-29
EMA Responds to Monkeypox Public Health Emergency
2022-07-28
WHO Sounds Monkeypox Alarm as Cases Continue Rising Worldwide
2022-07-07
LATEST
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top